Cross-talk between dopaminergic and noradrenergic systems in the rat ventral tegmental area, locus ceruleus, and dorsal hippocampus

Molecular Pharmacology

Volumn 74, Issue 5, 2008, Pages 1463-1475

  Guiard, Bruno P ^a   El Mansari, Mostafa ^a   Blier, Pierre ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; DESIPRAMINE; HALOPERIDOL; IDAZOXAN; RACLOPRIDE; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; HIPPOCAMPUS; LOCUS CERULEUS; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DOPAMINE; HIPPOCAMPUS; IDAZOXAN; IONTOPHORESIS; LOCUS COERULEUS; MALE; NEURONS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 54349083550     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.048033     Document Type: Article

References (54)

1. Aghajanian GK and Bunney BS (1977a) Dopamine "autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol 297:1-7.
2. Aghajanian GK and Bunney BS (1977b) Pharmacological characterization of dopamine "autoreceptors" by microiontophoretic single-cell recording studies. Adv Biochem Psychopharmacol 16:433-438.
3. Andén NE, Grabowska M, and Strömbom U (1976) Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn Schmiedebergs Arch Pharmacol 292:43-52.
4. Benardo LS and Prince DA (1982) Dopamine action on hippocampal pyramidal cells. J Neurosci 2:415-423.
5. Bischoff S, Heinrich M, Sonntag JM, and Krauss J (1986) The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors. Eur J Pharmacol 129:367-370.
6. Bischoff S, Scatton B, and Korf J (1979) Biochemical evidence for a transmitter role of dopamine in the rat hippocampus. Brain Res 165:161-165.
7. 3H]idazoxan in rat brain. J Pharmacol Exp Ther 241:1079-1091.
8. Bruinink A and Bischoff S (1993) Dopamine D2 receptors are unevenly distributed in the rat hippocampus and are modulated differently than in striatum. Eur J Pharmacol 245:157-164.
9. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, and Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711.
10. Carboni E and Silvagni A (2004) Dopamine reuptake by norepinephrine neurons: exception or rule? Crit Rev Neurobiol 16:121-128.
11. Cedarbaum JM and Aghajanian GK (1977) Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharmacol 44:375-385.
12. Chernoloz O, Mansari ME, and Blier P (2008) Sustained administration of pramipexole modifies the spontaneous firing rate of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology, in press.
13. Cohen BM and Lipinski JF (1986) In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action. Life Sci 39:2571-2580.
14. Cornil CA, Castelino CB, and Ball GF (2008) Dopamine binds to alpha2-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata). J Chem Neuroanat 35:202-215.
15. 3H]WB 4101 binding with noradrenergic innervation in the rat. Brain Res 182:107-117.
16. Curet O and de Montigny C (1988a) Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Res 475:35-46.
17. Curet O and de Montigny C (1988b) Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Res 475:47-57.
18. Dahlin A, Xia L, Kong W, Hevner R, and Wang J (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146:1193-1211.
19. Delis F, Mitsacos A, and Giompres P (2004) Dopamine receptor and transporter levels are altered in the brain of Purkinje cell degeneration mutant mice. Neuroscience 125:255-268.
20. Devoto P, Flore G, Pira L, Longu G, and Gessa GL (2004) Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487:105-111.
21. Doxey JC, Roach AG, and Smith CF (1983) Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol 78:489-505.
22. 3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 19:125-137.
23. Einhorn LC, Johansen PA, and White FJ (1988) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J Neurosci 8:100-112.
24. Elam M, Clark D, and Svensson TH (1986) Electrophysiological effects of the enantiomers of 3-PPP on neurons in the locus coeruleus of the rat. Neuropharmacology 25:1003-1008.
25. Freedman JE and Aghajanian GK (1984) Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons. Eur J Pharmacol 105:265-272.
26. Georges F and Aston-Jones G (2003) Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology 28:1140-1149.
27. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, and Caron MG (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269: 15985-15988.
28. Gobbi G, Muntoni AL, Gessa GL, and Diana M (2001) Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal. Psychopharmacology (Berl) 158:1-6.
29. Grenhoff J and Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233:79-84.
30. Grenhoff J, Nisell M, Ferré S, Aston-Jones G, and Svensson TH (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect 93:11-25.
31. Grenhoff J, North RA, and Johnson SW (1995) Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur J Neurosci 7:1707-1713.
32. Guiard BP, El Mansari M, Merali Z, and Blier P (2008) Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol 11:625-639.
33. Jones BE and Moore RY (1977) Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 127:25-53.
34. Lee A, Wissekerke AE, Rosin DL, and Lynch KR (1998) Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience 84:1085-1096.
35. Linnér L, Endersz H, Ohman D, Bengtsson F, Schalling M, and Svensson TH (2001) Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther 297:540-546.
36. Morón JA, Brockington A, Wise RA, Rocha BA, and Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22: 389-395.
37. Mueller AL, Palmer MR, Hoffer BJ, and Dunwiddie TV (1982) Hippocampal noradrenergic responses in vivo and in vitro. Characterization of alpha and beta components. Naunyn Schmiedebergs Arch Pharmacol 318:259-266.
38. 125I]epidepride, a high-affinity substituted benzamide ligand. J Pharmacol Exp Ther 252:1108-1116.
39. Newman-Tancredi A, Audinot-Bouchez V, Gobert A, and Millan MJ (1997) Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Eur J Pharmacol 319:379-383.
40. Nilsson LK, Schwieler L, Engberg G, Linderholm KR, and Erhardt S (2005) Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms. Int J Neuropsychopharmacol 8:329-339.
41. Ornstein K, Milon H, McRae-Degueurce A, Alvarez C, Berger B, and Würzner HP (1987) Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area. J Neural Transm 70:183-191.
42. Piercey MF, Smith MW, and Lum-Ragan JT (1994) Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties. J Pharmacol Exp Ther 268:1297-1303.
43. Scatton B, Simon H, Le Moal M, and Bischoff S (1980) Origin of dopaminergic innervation of the rat hippocampal formation. Neurosci Lett 18:125-131.
44. Segal M, Pickel V, and Bloom F (1973) The projections of the nucleus locus coeruleus: an autoradiographic study. Life Sci 13:817-821.
45. Simon H, Le Moal M, Stinus L, and Calas A (1979) Anatomical relationships between the ventral mesencephalic tegmentum - a 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques. J Neural Transm 44:77-86.
46. Svensson TH, Bunney BS, and Aghajanian GK (1975) Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 92:291-306.
47. Swanson LW and Hartman BK (1975) The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163:467-505.
48. Swanson LW (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321-353.
49. U'Prichard DC, Greenberg DA, and Snyder SH (1977) Binding characteristics of a radiolabeled agonist and antagonist at central nervous system α noradrenergic receptors. Mol Pharmacol 13:454-473.
50. Wedemeyer C, Goutman JD, Avale ME, Franchini LF, Rubinstein M, and Calvo DJ (2007) Functional activation by central monoamines of human dopamine D4 receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes. Eur J Pharmacol 562:165-173.
51. White FJ and Wang RY (1984a) A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci 34:1161-1170.
52. White FJ and Wang RY (1984b) Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J Pharmacol Exp Ther 231:275-280.
53. 3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. J Comp Neurol 344:121-136.
54. Zhang WP, Ouyang M, and Thomas SA (2004) Potency of catecholamines and other L-tyrosine derivatives at the cloned mouse adrenergic receptors. Neuropharmacology 47:438-449.